References
- Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818–1822.
- Borgstein PJ, Meijer S. Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997; 349: 1668–1669.
- Brown LF, Guidi AJ, Schiff SJ, et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clinical Cancer Research 1999; 5: 1041–1056.
- Cox CE, Pendas S. Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227: 645–653.
- Fisher B, Redmond C, et al. NSABP investigators: Ten-year results of a randomized clinical trial compar-ing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674–681.
- Halsted WS. The results of radical operations for the cure of the carcinoma of the breast. Ann Surg 1907; 46: 1.
- Lacour J, Bucalossi P. Caceres E, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an interna-tional cooperative study. Cancer 1976; 37: 206–214.
- Morton DL, Duan-Ren Wen, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392–399.
- Reintgen D, Wayne Guse C, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220: 759–767.
- Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864–1867.
- Veronesi U. The sentinel node and breast cancer. Br J Surg 1999; 86: 1–2.
- Yeatman J, Nicholson GL. Molecular basis of tumor progression: mechanisms of organ-specific tumor meta-stasis. Semin Oncol 1993; 9: 256–263.